Lost Money on Telix Pharmaceuticals Ltd. (TLX)? Contact Levi & Korsinsky to Join Class Action Before January 9, 2026

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / If you suffered a loss on your Telix Pharmaceuticals Ltd. (NASDAQ:TLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=179259&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Women and Investing: CIRO’s Investor Advisory Panel publishes inaugural research report

When working with advisors, women value returns, plain language, respect and understanding of life goals; confidence challenges persist The Canadian Investment Regulatory Organization's (CIRO) Investor Advisory Panel (IAP) has published research confirming that women invest less and feel less confident when it comes to investing, when compared with men. The report found that women save

New to The Street Announcing Applications to Attend FOB SUMMIT 2026 Are Now Open

NEW YORK CITY, NY / ACCESS Newswire / November 26, 2025 / NTTS and HPB today announced the return of FOB 2026: From Summit to Solution, taking place in New York City on March 10-11, 2026. Following the success of last year’s successful inaugural event, the Future of Batteries (FOB) Summit will once again bring

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

(NASDAQ:PRLD), LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prelude Therapeutics Incorporated (“Prelude” or “the Company”) (NASDAQ: PRLD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

Holding(s) in Company

(LSE:EDV),(TSX-V:EDV),(OTC US:EDVMF),(OTCQX:EDVMF), Endeavour Mining plc (“the Company”) announces that it received the following notification from BlackRock, Inc. of its interests in the Company as at 25 November 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6K5J42 Issuer Name ENDEAVOUR MINING PLC UK or Non-UK Issuer UK 2. Reason for Notification

Holding(s) in Company

Holding(s) in Company GlobeNewswire November 26, 2025 Endeavour Mining plc (“the Company”) announces that it received the following notification from BlackRock, Inc. of its interests in the Company as at 25 November 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6K5J42 Issuer Name ENDEAVOUR MINING PLC UK or Non-UK Issuer

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm GlobeNewswire November 26, 2025 LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prelude Therapeutics Incorporated (“Prelude” or “the

Lost Investment in Varonis Systems, Inc. (VRNS)? Levi & Korsinsky Launches Securities Fraud Investigation

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker

MoonLake Immunotherapeutics (MLTX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 15, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=179257&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Data Center Cooling Market to Hit USD 92,775.81 Mn by 2035, Growing at 15.50% CAGR – DC Market Insights

https://mma.prnewswire.com/media/2806204/DC_Market_Insights_Logo.jpg Market overview The Global Data Center Cooling Market size was valued at USD 10,617.23 million in 2020, increasing to USD 21,864.96 million in 2025, and is anticipated to reach USD 92,775.81 million by 2035, at a CAGR of 15.50% during the forecast period. The market growth reflects the rising penetration of hyperscale data centers,

Scroll to Top